Overview

A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function

Status:
Completed
Trial end date:
2018-10-26
Target enrollment:
Participant gender:
Summary
The study will investigate whether administration of clazosentan can affect normal heart function in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Idorsia Pharmaceuticals Ltd.
Treatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination